Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Urban Novak

Showing results (41-50 of 103) with videos related to

Pageof 11
Sort By:
Hemasphere|December 4, 2023
CAR-T Cell Therapy Shows Similar Efficacy and Toxicity in Patients With DLBCL Regardless of CNS InvolvementEvgenii Shumilov, Hristo Boyadzhiev, Paolo Mazzeo, et al.
International Journal of Cancer|July 16, 2015
HIV and human herpesvirus 8 co-infection across the globe: Systematic review and meta-analysisEliane Rohner, Natascha Wyss, Zina Heg, et al.
Hematological Oncology|February 18, 2015
Zevalin and BEAM (Z-BEAM) versus rituximab and BEAM (R-BEAM) conditioning chemotherapy prior to autologous stem cell transplantation in patients with mantle cell lymphomaMartin D Berger, Giacomo Branger, Bernd Klaeser, et al.
Haematologica|June 20, 2020
Impact on survival through consolidation radiotherapy for diffuse large B-cell lymphoma: a comprehensive meta-analysisMartin D Berger, Sven Trelle, Annina E Büchi, et al.
Leukemia & Lymphoma|April 4, 2019
Improved survival rates of AML patients following admission to the intensive care unitPriska Fassbind, Barbara Jeker, Beatrice U Mueller, et al.
Hematological Oncology|January 25, 2018
Prolonged survival after second autologous transplantation and lenalidomide maintenance for salvage treatment of myeloma patients at first relapse after prior autograftUrsina Gössi, Barbara Jeker, Behrouz Mansouri Taleghani, et al.
Haematologica|November 2, 2018
TIRAP p.R81C is a novel lymphoma risk variant which enhances cell proliferation <i>via</i> NF-κB mediated signaling in B-cellsRegula Burkhard, Irene Keller, Miroslav Arambasic, et al.
Blood Cancer Journal|November 14, 2018
Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine useUlrike Bacher, Evgenii Shumilov, Johanna Flach, et al.
International Journal of Molecular Sciences|August 29, 2024
A Comprehensive ddPCR Strategy for Sensitive and Reliable Monitoring of CAR-T Cell Kinetics in Clinical ApplicationsGertrud Wiedemann, Ulrike Bacher, Raphael Joncourt, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|July 31, 2023
Correlation of Peripheral Chimeric Antigen Receptor T-cell (CAR-T Cell) mRNA Expression Levels with Toxicities and Outcomes in Patients with Diffuse Large B-cell LymphomaChristian Messerli, Gertrud Wiedemann, Naomi Porret, et al.
Pageof 11

Showing results (41-50 of 103) with videos related to

Sort By:
Pageof 11
Hemasphere|December 4, 2023
CAR-T Cell Therapy Shows Similar Efficacy and Toxicity in Patients With DLBCL Regardless of CNS InvolvementEvgenii Shumilov, Hristo Boyadzhiev, Paolo Mazzeo, et al.
International Journal of Cancer|July 16, 2015
HIV and human herpesvirus 8 co-infection across the globe: Systematic review and meta-analysisEliane Rohner, Natascha Wyss, Zina Heg, et al.
Hematological Oncology|February 18, 2015
Zevalin and BEAM (Z-BEAM) versus rituximab and BEAM (R-BEAM) conditioning chemotherapy prior to autologous stem cell transplantation in patients with mantle cell lymphomaMartin D Berger, Giacomo Branger, Bernd Klaeser, et al.
Haematologica|June 20, 2020
Impact on survival through consolidation radiotherapy for diffuse large B-cell lymphoma: a comprehensive meta-analysisMartin D Berger, Sven Trelle, Annina E Büchi, et al.
Leukemia & Lymphoma|April 4, 2019
Improved survival rates of AML patients following admission to the intensive care unitPriska Fassbind, Barbara Jeker, Beatrice U Mueller, et al.
Hematological Oncology|January 25, 2018
Prolonged survival after second autologous transplantation and lenalidomide maintenance for salvage treatment of myeloma patients at first relapse after prior autograftUrsina Gössi, Barbara Jeker, Behrouz Mansouri Taleghani, et al.
Haematologica|November 2, 2018
TIRAP p.R81C is a novel lymphoma risk variant which enhances cell proliferation <i>via</i> NF-κB mediated signaling in B-cellsRegula Burkhard, Irene Keller, Miroslav Arambasic, et al.
Blood Cancer Journal|November 14, 2018
Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine useUlrike Bacher, Evgenii Shumilov, Johanna Flach, et al.
International Journal of Molecular Sciences|August 29, 2024
A Comprehensive ddPCR Strategy for Sensitive and Reliable Monitoring of CAR-T Cell Kinetics in Clinical ApplicationsGertrud Wiedemann, Ulrike Bacher, Raphael Joncourt, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|July 31, 2023
Correlation of Peripheral Chimeric Antigen Receptor T-cell (CAR-T Cell) mRNA Expression Levels with Toxicities and Outcomes in Patients with Diffuse Large B-cell LymphomaChristian Messerli, Gertrud Wiedemann, Naomi Porret, et al.
Pageof 11